BIOMAT Database Logo BIOMAT Database Logo

Treatment of heroin dependence with opiate antagonists. 1970

M Fink, and A Zaks, and R Resnick, and A M Freedman

UI MeSH Term Description Entries
D008297 Male Males
D009019 Morphinans Compounds based on a partially saturated iminoethanophenanthrene, which can be described as ethylimino-bridged benzo-decahydronaphthalenes. They include some of the OPIOIDS found in PAPAVER that are used as ANALGESICS. Morphinan
D009292 Narcotic Antagonists Agents inhibiting the effect of narcotics on the central nervous system. Competitive Opioid Antagonist,Narcotic Antagonist,Opioid Antagonist,Opioid Antagonists,Opioid Receptor Antagonist,Opioid Reversal Agent,Competitive Opioid Antagonists,Opioid Receptor Antagonists,Opioid Reversal Agents,Agent, Opioid Reversal,Agents, Opioid Reversal,Antagonist, Competitive Opioid,Antagonist, Narcotic,Antagonist, Opioid,Antagonist, Opioid Receptor,Antagonists, Competitive Opioid,Antagonists, Narcotic,Antagonists, Opioid,Antagonists, Opioid Receptor,Opioid Antagonist, Competitive,Opioid Antagonists, Competitive,Receptor Antagonist, Opioid,Receptor Antagonists, Opioid,Reversal Agent, Opioid,Reversal Agents, Opioid
D001952 Bridged-Ring Compounds Cyclic hydrocarbons that contain multiple rings which share one or more bridgehead connections. Bridged Compounds,Bridged Ring Compounds
D003932 Heroin A narcotic analgesic that may be habit-forming. It is a controlled substance (opium derivative) listed in the U.S. Code of Federal Regulations, Title 21 Parts 329.1, 1308.11 (1987). Sale is forbidden in the United States by Federal statute. (Merck Index, 11th ed) Diacetylmorphine,Diamorphine,Diacetylmorphine Hydrochloride,Diagesil,Diamorf,Heroin Hydrochloride,Min-I-Jet Morphine Sulphate,Hydrochloride, Diacetylmorphine,Hydrochloride, Heroin,Min I Jet Morphine Sulphate
D004336 Drug Antagonism Phenomena and pharmaceutics of compounds that inhibit the function of agonists (DRUG AGONISM) and inverse agonists (DRUG INVERSE AGONISM) for a specific receptor. On their own, antagonists produce no effect by themselves to a receptor, and are said to have neither intrinsic activity nor efficacy. Antagonism, Drug,Antagonisms, Drug,Drug Antagonisms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001392 Azocines
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

M Fink, and A Zaks, and R Resnick, and A M Freedman
Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
January 1995, Journal of substance abuse treatment,
M Fink, and A Zaks, and R Resnick, and A M Freedman
Narcotic antagonists in opiate dependence.
September 1970, Science (New York, N.Y.),
M Fink, and A Zaks, and R Resnick, and A M Freedman
Diamorphine treatment for opiate dependence: putative markers of concomitant heroin misuse.
July 2001, Addiction biology,
M Fink, and A Zaks, and R Resnick, and A M Freedman
[Rapid induction of withdrawal with opiate antagonists under anesthesia: an alternative to treatment of opiate dependence?].
October 2002, Praxis,
M Fink, and A Zaks, and R Resnick, and A M Freedman
Treatment of heroin dependence with naltrexone.
January 1975, Current psychiatric therapies,
M Fink, and A Zaks, and R Resnick, and A M Freedman
Heroin-assisted treatment as a response to the public health problem of opiate dependence.
September 2002, European journal of public health,
M Fink, and A Zaks, and R Resnick, and A M Freedman
Treatment of heroin dependence.
April 2001, Annals of internal medicine,
M Fink, and A Zaks, and R Resnick, and A M Freedman
Treatment of heroin dependence.
January 2001, Annals of internal medicine,
M Fink, and A Zaks, and R Resnick, and A M Freedman
Sustained-release opiate blockers for treating heroin and amphetamine dependence.
May 2012, The American journal of psychiatry,
M Fink, and A Zaks, and R Resnick, and A M Freedman
Methadone treatment of heroin dependence.
September 1974, Rocky Mountain medical journal,
Copied contents to your clipboard!